Deposition of nanoparticles in the infant lung

F. Henry, A. Tsuda (Boston, MA, United States Of America)

Source: Annual Congress 2007 - Advances in respiratory mechanics
Session: Advances in respiratory mechanics
Session type: Electronic Poster Discussion
Number: 1637
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Henry, A. Tsuda (Boston, MA, United States Of America). Deposition of nanoparticles in the infant lung. Eur Respir J 2007; 30: Suppl. 51, 1637

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Measuring peripheral lung dimensions with the deposition of aerosol nanoparticles
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021


Retention of ultrafine particles in the human lung
Source: Eur Respir J 2004; 24: Suppl. 48, 236s
Year: 2004

Deposition of ultrafine (nano)particles in the human lung and the mechanisms behing the health effects
Source: International Congress 2014 – Nanomaterials and respiratory health
Year: 2014



Micron-sized particle deposition in the developing rodent lung
Source: Annual Congress 2011 - Important new developments in paediatric respiratory physiology
Year: 2011


Imaging of the interaction of fine particles and nanoparticles with lung cells
Source: Annual Congress 2009 - WS1 - New imaging methods for the researcher: believe what you see!
Year: 2009



Deposition of aerosols in the lung periphery of patients with lung emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 212s
Year: 2001

Pulmonary toxicity of cerium oxide nanoparticle following intratracheal instillation and inhalation of nanoparticles
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015

Cell-derived microparticles and the lung
Source: Eur Respir Rev 2016; 25: 266-277
Year: 2016



NiO and Co3O4 nanoparticles induce lung DTH-like responses and alveolar lipoproteinosis
Source: Eur Respir J 2012; 39: 546-557
Year: 2012



Slow particle dissolution may limit lung absorption of inhaled pharmaceuticals in the lungs
Source: Eur Respir J 2006; 28: Suppl. 50, 210s
Year: 2006

Effect of avidin protein coated and uncoated mesoporous silica drug nanocarriers on their bioresponse in the lung
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014

Acute lung exposure to alumina dust and aluminium oxide in mice
Source: Annual Congress 2010 - Lung morbidity on exposure to various agents
Year: 2010


Inhaled solid lipid nanoparticles as a new tool for drug delivery in the lung
Source: Annual Congress 2009 - New drugs for airways disease
Year: 2009


Bioreactivity and fate of nanoparticles deposited at the pulmonary epithelial interface: focus on traffic-derived particulate matter
Source: International Congress 2016 – Traffic air pollution in urban areas
Year: 2016


Lung deposition of 99mTc-DTPA delivered with an adaptive aerosol delivery system
Source: Eur Respir J 2007; 30: Suppl. 51, 545s
Year: 2007

Improving surfactant therapy: Development of a neonatal upper airway model for in vitro aerosol deposition testing
Source: Annual Congress 2013 –Neonatal and paediatric intensive care
Year: 2013

Lung deposition of an aerosol produced by a new inhalation device for ventilated patients
Source: Eur Respir J 2005; 26: Suppl. 49, 88s
Year: 2005